242 related articles for article (PubMed ID: 8381709)
41. [Trophoblastic disease in data from the Center for Trophoblastic Disease (diagnosis, therapy and results form 1955 to 1996). 1].
Zavadil M
Ceska Gynekol; 1997 Apr; 62(2):67-71. PubMed ID: 9296795
[TBL] [Abstract][Full Text] [Related]
42. [Case report and literature review of epithelioid trophoblastic tumor].
Cheng XD; Lü WG; Wan XY; Chen XD; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):281-5. PubMed ID: 18843970
[TBL] [Abstract][Full Text] [Related]
43. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
44. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
45. [Diagnosis and treatment of trophoblastic uterine tumors].
Kozachenko VP; Toloknov BO; Savinova VF; Grigorova TM
Vopr Onkol; 1982; 28(5):97-103. PubMed ID: 6283736
[TBL] [Abstract][Full Text] [Related]
46. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
47. Disease of the trophoblast.
Ratnam SS; Ilancheran A
Clin Obstet Gynaecol; 1982 Dec; 9(3):539-64. PubMed ID: 6293752
[TBL] [Abstract][Full Text] [Related]
48. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
49. [Hydatidiform mole and malignant trophoblastic tumors initiated by hydatidiform mole. Standards and innovation of diagnosis and treatment].
Tsip NP
Vopr Onkol; 2014; 60(3):396-401. PubMed ID: 25033699
[TBL] [Abstract][Full Text] [Related]
50. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
51. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
Luschin-Ebengreuth G; Petru E; Pickel H
Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():125-6. PubMed ID: 1337488
[No Abstract] [Full Text] [Related]
52. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
53. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
Huang SC; Hsieh CY; Ouyang PC
J Formos Med Assoc; 1991 Jan; 90(1):53-8. PubMed ID: 1679110
[TBL] [Abstract][Full Text] [Related]
54. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
55. The significance of proliferating cell nuclear antigen in human trophoblastic disease: an immunohistochemical study.
Cheung AN; Ngan HY; Chen WZ; Loke SL; Collins RJ
Histopathology; 1993 Jun; 22(6):565-8. PubMed ID: 8102616
[TBL] [Abstract][Full Text] [Related]
56. Poor-prognosis metastatic gestational trophoblastic neoplasia.
Hammond CB; Soper JT
Clin Obstet Gynecol; 1984 Mar; 27(1):228-39. PubMed ID: 6323081
[TBL] [Abstract][Full Text] [Related]
57. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic profile of gestational trophoblastic disease.
Jelincic D; Hudelist G; Singer CF; Bauer M; Horn LC; Bilek K; Czerwenka K
Wien Klin Wochenschr; 2003 Jan; 115(1-2):29-35. PubMed ID: 12658908
[TBL] [Abstract][Full Text] [Related]
59. Gestational trophoblastic diseases: new standards for therapy.
Cohn DE; Herzog TJ
Curr Opin Oncol; 2000 Sep; 12(5):492-6. PubMed ID: 10975558
[TBL] [Abstract][Full Text] [Related]
60. Identification and management of high-risk gestational trophoblastic disease.
Soper JT
Semin Oncol; 1995 Apr; 22(2):172-84. PubMed ID: 7740319
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
